Lyxor Tiedemann (Ireland) Buy Hold or Sell Recommendation

    F00000QESG -- Ireland Fund  

    EUR 106.00  0.24  0.23%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Lyxor Tiedemann Arbitrage Strat A EUR is 'Not Rated'. Macroaxis provides Lyxor Tiedemann buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding F00000QESG positions. The advice algorithm takes into account all of Lyxor Tiedemann Arbi available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from F00000QESG buy-and-hold prospective. Additionally see Investing Opportunities.

    Time Horizon

    Risk Tolerance

    Execute Advice
    Sell Lyxor TiedemannBuy Lyxor Tiedemann
    Not Rated
    For the selected time horizon Lyxor Tiedemann Arbitrage Strat A EUR has a risk adjusted performance of 0.0454, jensen alpha of 0.0469, total risk alpha of 0.22, sortino ratio of 0.0 and treynor ratio of 0.4484
    Macroaxis provides buy or sell recommendations on Lyxor Tiedemann Arbi to complement and cross-verify current analyst consensus on Lyxor Tiedemann. Our advice engine determines the entity potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. Please be advised to verify Lyxor Tiedemann Arbitrage Strat A EUR Minimum Initial Investment to validate our buy or sell recommendation.

    Lyxor Tiedemann Returns Distribution Density

    Mean Return0.08Value At Risk1.5
    Potential Upside2.20Standard Deviation0.95
     Return Density 

    Did You Try This Idea?

    Run Medical Equipment Thematic Idea Now

    Medical Equipment
    Medical Equipment Idea
    Fama and French focuses on testing asset pricing under different economic assumptions. Medical Equipment theme has 61 constituents.
    View All  Next Launch Medical Equipment
    Additionally see Investing Opportunities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.